XORTX Therapeutics XRTX
NASDAQ XRTX
$1.73 +0.04 (+2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Beginning Cash Balance (2021 - 2026)

Updated

XORTX Therapeutics (XRTX) recorded Beginning Cash Balance of $864,514 in the quarter ended Mar 31, 2026, down 65.1% from $2.47 million a year earlier.

Analysis

XORTX Therapeutics (XRTX) Beginning Cash Balance (2021 - 2026) Analysis & Trends

For the year ended Dec 31, 2022, XORTX Therapeutics reported Beginning Cash Balance of $14.5 million.

  • Across earlier years, Beginning Cash Balance came in at $136,667 in the year ended Dec 31, 2021 (+212.4%) and $43,754 in the year ended Dec 31, 2020.
  • The figure for the quarter ended Mar 31, 2026 is the lowest quarterly Beginning Cash Balance since the quarter ended Mar 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 864,514.00
Mar 31, 2025 2.47 Mn
Mar 31, 2024 3.45 Mn
Mar 31, 2023 10.43 Mn
Mar 31, 2022 14.88 Mn
Mar 31, 2021 135,321.07
API Access

XORTX Therapeutics Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=XRTX&period=max&api_key=YOUR_API_KEY